Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$900M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$866M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$596M |
| 4 |
Clarivate
CLVT
|
+$284M |
| 5 |
Mastercard
MA
|
+$272M |
Top Sells
| 1 |
Wolfspeed
WOLF
|
+$1.11B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1,000M |
| 3 |
Apple
AAPL
|
+$925M |
| 4 |
Intel
INTC
|
+$462M |
| 5 |
Microsoft
MSFT
|
+$435M |
Sector Composition
| 1 | Technology | 25.57% |
| 2 | Financials | 13.1% |
| 3 | Healthcare | 12.32% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFI
3001
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $900K | ﹤0.01% |
247,910
-5,882
| -2% | -$21.4K |
|
3002
Investors Title Co
ITIC
$471M
| $899K | ﹤0.01% |
4,913
-885
| -15% | -$162K |
|
3003
Vor Biopharma
VOR
$251M
| $899K | ﹤0.01% |
58,523
+10,321
| +21% | +$159K |
|
|
BRT
3004
BRT Apartments
BRT
$283M
| $891K | ﹤0.01% |
46,300
-2,200
| -5% | -$42.3K |
|
|
USX
3005
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $891K | ﹤0.01% |
103,812
+7,099
| +7% | +$60.9K |
|
3006
Gaotu Techedu
GOTU
$877M
| $888K | ﹤0.01% |
288,995
+127,117
| +79% | +$391K |
|
|
CS
3007
DELISTED
Credit Suisse Group
CS
| $885K | ﹤0.01% |
89,720
-5,065
| -5% | -$50K |
|
3008
Laird Superfood
LSF
$61.3M
| $883K | ﹤0.01% |
46,283
+5,149
| +13% | +$98.2K |
|
|
PZN
3009
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $878K | ﹤0.01% |
90,773
-1,049
| -1% | -$10.1K |
|
3010
ClearPoint Neuro
CLPT
$311M
| $874K | ﹤0.01% |
44,545
| – | – |
|
3011
Black Diamond Therapeutics
BDTX
$174M
| $873K | ﹤0.01% |
91,877
+1,230
| +1% | +$11.7K |
|
3012
Blue Foundry Bancorp
BLFY
$203M
| $872K | ﹤0.01% |
+63,241
| New | +$872K |
|
3013
Flexsteel Industries
FLXS
$256M
| $872K | ﹤0.01% |
23,827
-231
| -1% | -$8.45K |
|
3014
Atlanta Braves Holdings Series A
BATRA
$2.92B
| $868K | ﹤0.01% |
32,781
-491
| -1% | -$13K |
|
3015
Coastal Financial
CCB
$1.66B
| $867K | ﹤0.01% |
27,592
-1,694
| -6% | -$53.2K |
|
|
SURF
3016
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $867K | ﹤0.01% |
122,099
+22,983
| +23% | +$163K |
|
3017
Lifetime Brands
LCUT
$93.3M
| $866K | ﹤0.01% |
49,970
-3,438
| -6% | -$59.6K |
|
|
DZSI
3018
DELISTED
DZS Inc. Common Stock
DZSI
| $864K | ﹤0.01% |
64,953
-1,341
| -2% | -$17.8K |
|
|
PSTX
3019
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $862K | ﹤0.01% |
107,684
+8,288
| +8% | +$66.3K |
|
3020
MaxCyte
MXCT
$150M
| $858K | ﹤0.01% |
+70,232
| New | +$858K |
|
3021
Daktronics
DAKT
$854M
| $854K | ﹤0.01% |
158,133
-3,213
| -2% | -$17.4K |
|
3022
Bridgford Foods
BRID
$72.2M
| $849K | ﹤0.01% |
70,834
| – | – |
|
3023
Universal Logistics Holdings
ULH
$673M
| $847K | ﹤0.01% |
43,312
-16,167
| -27% | -$316K |
|
|
EVLO
3024
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $847K | ﹤0.01% |
5,077
-343
| -6% | -$57.2K |
|
3025
Teekay
TK
$718M
| $846K | ﹤0.01% |
256,387
+3,063
| +1% | +$10.1K |
|